Warning letter
Town and Country Compounding and Consultation Services, LLC: warning letter of Oct 17, 2017
FDA warning letter 518371 · New Jersey District Office
Key facts
| Reference number | 518371 |
|---|---|
| Company | Town and Country Compounding and Consultation Services, LLC |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Oct 17, 2017 |
| Posted date | Oct 31, 2017 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| CFR sections cited | 210.1(b), 211.42(c)(10)(v), 211.42(d), 211.113(b), 211.192, 200.10(b) |
| Inspection city | Ramsey |
| Inspection ZIP | 07446 |
| Inspection start date | Jul 19, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: